5-羟基-2-(4-羟基苯基)-3-(((2S,3R,4S,5R,6R)-3,4,5-三羟基-6-((((2R,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-氧基))甲基)四氢-2H-吡喃-2-氧基))-7-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-氧基))-4H-苯并吡喃-4-酮

9-((2R,3S,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-3H-嘌呤-6(9H)-酮

二苯基胺 盐酸盐

2-氯-6-(哌啶-4-基硫基)吡啶 盐酸盐

Immunoglobulin G4, anti-(human vimentin) (human-Mus musculus γ4-chain), disulfide with human-Mus musculus κ-chain, dimer (ACI)

Immunoglobulin, anti-(human cytotoxic T-lymphocyte-associated protein 4) (human-Mus musculus monoclonal XmAb20717 single-chain variable fragment VL-linker-VH) fusion protein with immunoglobulin G1 (human γ1-chain C-region C-terminal fragment), (260→227′),(263→230′)-bis(disulfide) with immunoglobulin G1 anti-(human programmed cell death 1) (human-Mus musculus monoclonal XmAb20717 γ1-chain) disulfide with human-Mus musculus monoclonal XmAb20717 κ-chain (ACI)

Sibrotuzumab

DNA d(P-thio)([2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]rG-G-T-T-A-m5C-A-T-G-A-A-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]m5rC) (ACI)

(E)-甲基 2-((1'S,6'R,7'S,8a'S)-6'-乙基-2-氧代-3',5',6',7',8',8a'-六氢-2'H-螺[吲哚啉-3,1'-中氮茚]-7'-基)-3-甲氧基丙烯酸酯

4-碘-1,5-二甲基-2-苯基-1H-吡唑-3(2H)-酮

5,7-二羟基-3-(3-羟基-4-甲氧基苯基)-4H-苯并吡喃-4-酮

(R)-4-(3-(环戊氧基)-4-甲氧基苯基)吡咯烷-2-酮

4-甲氧基-6-甲基-5,6,7,8-四氢-[1,3]二氧杂环戊烷并[4,5-g]异喹啉

(R)-1-甲氧基-6-甲基-5,6,6a,7-四氢-4H-二苯并[de,g]喹啉-2-醇

(E)-1-(2-羟基-4,6-二甲氧基苯基)-3-(4-羟基苯基)丙-2-烯-1-酮

(E)-3-(2,3-二甲氧基苯基)-1-(4-甲氧基苯基)丙-2-烯-1-酮

(3aR,4aR,8aR,9aR)-4a-羟基-8a-甲基-3,5-二亚甲基十氢萘并[2,3-b]呋喃-2(3H)-酮

Maytansine, N2′-deacetyl-N2′-[3-(methyldithio)-1-oxopropyl]- (9CI, ACI)

7,8-二羟基-3-(4-羟基苯基)-4H-苯并吡喃-4-酮

3-(2-(4-(双(4-氟苯基)亚甲基)哌啶-1-基)乙基)-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮

2-苯甲酰基环己酮